Abstract
Extracorporeal Membrane Oxygenation (ECMO) represents a useful tool to support the lungs and the heart when all conventional therapies failed and the patients are at risk of death. While the Extracorporeal Life Support Organization (ELSO) collects data from different institutions that joined the Registry and reports overall outcome, individual centres often collide with results below expectations, either in adults and in paediatric population. Some authors suggest that poor outcomes could be overcome with a programme dedicated to ECMO, with specialized professionals adequately trained on ECMO and with a consistent number of procedures. In 2012, The IRCCS PSD ECMO Programme was instituted with the specific aim of achieving better results than hitherto obtained. After only 1 year of activity, the results justified the programme, with a better survival rate for each group investigated, particularly in adults, but surprisingly in paediatrics too, where the results were better than what reported by ELSO. Although the number of patients treated with ECMO is still growing up, the effects of the ECMO programme continue to exert a positive action on outcome even now. The present article reports data on survival, blood loss, and blood consumption during ECMO in the last few years at our institution.
| Original language | English |
|---|---|
| Pages (from-to) | E79-E85 |
| Journal | European Heart Journal, Supplement |
| Volume | 18 |
| DOIs | |
| Publication status | Published - Apr 28 2016 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Modern ECMO : Why an ECMO programme in a tertiary care hospital. / Cotza, Mauro; Carboni, Giovanni; Ballotta, Andrea; Kandil, Hassan; Isgrò, Giuseppe; Carlucci, Concetta; Varrica, Alessandro; Garatti, Andrea; Giamberti, Alessandro; Ranucci, Marco.
In: European Heart Journal, Supplement, Vol. 18, 28.04.2016, p. E79-E85.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Modern ECMO
T2 - Why an ECMO programme in a tertiary care hospital
AU - Cotza, Mauro
AU - Carboni, Giovanni
AU - Ballotta, Andrea
AU - Kandil, Hassan
AU - Isgrò, Giuseppe
AU - Carlucci, Concetta
AU - Varrica, Alessandro
AU - Garatti, Andrea
AU - Giamberti, Alessandro
AU - Ranucci, Marco
PY - 2016/4/28
Y1 - 2016/4/28
N2 - Extracorporeal Membrane Oxygenation (ECMO) represents a useful tool to support the lungs and the heart when all conventional therapies failed and the patients are at risk of death. While the Extracorporeal Life Support Organization (ELSO) collects data from different institutions that joined the Registry and reports overall outcome, individual centres often collide with results below expectations, either in adults and in paediatric population. Some authors suggest that poor outcomes could be overcome with a programme dedicated to ECMO, with specialized professionals adequately trained on ECMO and with a consistent number of procedures. In 2012, The IRCCS PSD ECMO Programme was instituted with the specific aim of achieving better results than hitherto obtained. After only 1 year of activity, the results justified the programme, with a better survival rate for each group investigated, particularly in adults, but surprisingly in paediatrics too, where the results were better than what reported by ELSO. Although the number of patients treated with ECMO is still growing up, the effects of the ECMO programme continue to exert a positive action on outcome even now. The present article reports data on survival, blood loss, and blood consumption during ECMO in the last few years at our institution.
AB - Extracorporeal Membrane Oxygenation (ECMO) represents a useful tool to support the lungs and the heart when all conventional therapies failed and the patients are at risk of death. While the Extracorporeal Life Support Organization (ELSO) collects data from different institutions that joined the Registry and reports overall outcome, individual centres often collide with results below expectations, either in adults and in paediatric population. Some authors suggest that poor outcomes could be overcome with a programme dedicated to ECMO, with specialized professionals adequately trained on ECMO and with a consistent number of procedures. In 2012, The IRCCS PSD ECMO Programme was instituted with the specific aim of achieving better results than hitherto obtained. After only 1 year of activity, the results justified the programme, with a better survival rate for each group investigated, particularly in adults, but surprisingly in paediatrics too, where the results were better than what reported by ELSO. Although the number of patients treated with ECMO is still growing up, the effects of the ECMO programme continue to exert a positive action on outcome even now. The present article reports data on survival, blood loss, and blood consumption during ECMO in the last few years at our institution.
UR - http://www.scopus.com/inward/record.url?scp=84966659343&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84966659343&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/suw016
DO - 10.1093/eurheartj/suw016
M3 - Article
AN - SCOPUS:84966659343
VL - 18
SP - E79-E85
JO - European Heart Journal, Supplement
JF - European Heart Journal, Supplement
SN - 1520-765X
ER -